Characterization and preclinical development of LY2603618: a selective and potent Chkl inhibitorKING, Constance; DIAZ, Henry; BARNARD, Darlene et al.Investigational new drugs. 2014, Vol 32, Num 2, pp 213-226, issn 0167-6997, 14 p.Article

Current status of robotic liver resection: a systematic reviewBUCHS, Nicolas C; OLDANI, Graziano; ORCI, Lorenzo A et al.Expert review of anticancer therapy. 2014, Vol 14, Num 2, pp 237-246, issn 1473-7140, 10 p.Article

Emerging Immunologic Biomarkers: Setting the (TNM-Immune) StageTAUBE, Janis M.Clinical cancer research (Print). 2014, Vol 20, Num 8, pp 2023-2025, issn 1078-0432, 3 p.Article

FcγRIIa and FcγRIIIa Polymorphisms and Cetuximab Benefit in the Microscopic DiseaseSCLAFANI, Francesco; DE CASTRO, David Gonzalez; TAIT, Diana et al.Clinical cancer research (Print). 2014, Vol 20, Num 17, pp 4511-4519, issn 1078-0432, 9 p.Article

Is oral chemotherapy prescription safe for patients? A cross-sectional surveyBOURMAUD, A; PACAUT, C; MELIS, A et al.Annals of oncology. 2014, Vol 25, Num 2, pp 500-504, issn 0923-7534, 5 p.Article

Molecular Pathways: Resistance to Kinase Inhibitors and Implications for Therapeutic StrategiesLOVLY, Christine M; SHAW, Alice T.Clinical cancer research (Print). 2014, Vol 20, Num 9, pp 2249-2256, issn 1078-0432, 8 p.Article

Molecular Pathways: Targeting Death Receptors and Smac MimeticsFULDA, Simone.Clinical cancer research (Print). 2014, Vol 20, Num 15, pp 3915-3920, issn 1078-0432, 6 p.Article

NSAIDs Inhibit Tumorigenesis, but How?GURPINAR, Evrim; GRIZZLE, William E; PIAZZA, Gary A et al.Clinical cancer research (Print). 2014, Vol 20, Num 5, pp 1104-1113, issn 1078-0432, 10 p.Article

Oxford and the Savannah: Can the Hippo Provide an Explanation for Peto's Paradox?KELLEHER, Fergal C; O'SULLIVAN, Hazel.Clinical cancer research (Print). 2014, Vol 20, Num 3, pp 557-564, issn 1078-0432, 8 p.Article

Phase I clinical trial of pegylated liposomal mitoxantrone plm60-s: pharmacokinetics, toxicity and preliminary efficacyJIANLIANG YANG; YUANKAI SHI; SHUXIANG ZHANG et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 3, pp 637-646, issn 0344-5704, 10 p.Article

Prevalence and Characteristics of MUTYH-Associated Polyposis in Patients with Multiple Adenomatous and Serrated PolypsGUARINOS, Carla; JUAREZ, Miriam; SERRADESANFERM, Anna et al.Clinical cancer research (Print). 2014, Vol 20, Num 5, pp 1158-1168, issn 1078-0432, 11 p.Article

RNAi Screen Identifies a Synthetic Lethal Interaction between PIM1 Overexpression and PLK1 InhibitionVAN DER MEER, Riet; HA YONG SONG; PARK, Seong-Hoon et al.Clinical cancer research (Print). 2014, Vol 20, Num 12, pp 3211-3221, issn 1078-0432, 11 p.Article

Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposalVALENT, P; SOTLAR, K; HAGGLUND, H et al.Annals of oncology. 2014, Vol 25, Num 9, pp 1691-1700, issn 0923-7534, 10 p.Article

Resistance mechanisms of cancer cells to the novel vacuolar H⁺-ATPase inhibitor archazolid BHAMM, Rebecca; SUGIMOTO, Yoshikazu; STEINMETZ, Heinrich et al.Investigational new drugs. 2014, Vol 32, Num 5, pp 893-903, issn 0167-6997, 11 p.Article

Role of pregnane X receptor in chemotherapeutic treatmentWEI ZHUO; LEI HU; JINFENG LV et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 2, pp 217-227, issn 0344-5704, 11 p.Article

Selective cellular uptake and retention of SN 28049, a new DNA-binding topoisomerase II-directed antitumor agentYING YI CHEN; LUKKA, Pradeep B; JOSEPH, Wayne R et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 1, pp 25-35, issn 0344-5704, 11 p.Article

Similarities and Differences in the Oncology Drug Approval Process between FDA and European Union with Emphasis on In Vitro Companion Diagnostics : PRECISION MEDICINESENDEROWICZ, Adrian M; PFAFF, Otmar.Clinical cancer research (Print). 2014, Vol 20, Num 6, pp 1445-1452, issn 1078-0432, 8 p.Article

Targeting P13K/mTOR Overcomes Resistance to HER2-Targeted Therapy Independent of Feedback Activation of AKTO'BRIEN, Neil A; MCDONALD, Karen; FINN, Richard S et al.Clinical cancer research (Print). 2014, Vol 20, Num 13, pp 3507-3520, issn 1078-0432, 14 p.Article

U.S. Food and Drug Administration Inspections of Clinical Investigators: Overview of Results from 1977 to 2009MORGAN-LINNELL, Sonia K; STEWART, David J; KURZROCK, Razelle et al.Clinical cancer research (Print). 2014, Vol 20, Num 13, pp 3364-3370, issn 1078-0432, 7 p.Article

Vitamin D Deficiency Predicts Prostate Biopsy OutcomesMURPHY, Adam B; NYAME, Yaw; MARTIN, Iman K et al.Clinical cancer research (Print). 2014, Vol 20, Num 9, pp 2289-2299, issn 1078-0432, 11 p.Article

Cytology of the LungZYDOWICZ, Sara; YELDANDI, Anjana; RAPARIA, Kirtee et al.Cancer treatment and research. 2014, Vol 160, pp 59-82, issn 0927-3042, 24 p.Article

Extra Virgin Olive Oil: From Composition to Molecular GastronomySACCHI, Raffaele; PADUANO, Antonello; SAVARESE, Maria et al.Cancer treatment and research. 2014, Vol 159, pp 325-338, issn 0927-3042, 14 p.Conference Paper

A Pilot Study Examining Circulating Interleukin-6 and Transforming Growth Factor-β Levels During Pelvic Radiation TherapyHALLEMEIER, Christopher L; IOTT, Matt J; MARTENSON, James A et al.American journal of clinical oncology. 2013, Vol 36, Num 4, pp 344-347, issn 0277-3732, 4 p.Article

A meta-analysis of the effects of chemotherapy on cognition in patients with cancerHODGSON, Kristy D; HUTCHINSON, Amanda D; WILSON, Carlene J et al.Cancer treatment reviews. 2013, Vol 39, Num 3, pp 297-304, issn 0305-7372, 8 p.Article

Aberrant BAF57 Signaling Facilitates Prometastatic PhenotypesBALASUBRAMANIAM, Sucharitha; COMSTOCK, Clay E. S; ERTEL, Adam et al.Clinical cancer research (Print). 2013, Vol 19, Num 10, pp 2657-2667, issn 1078-0432, 11 p.Article